Coherus Oncology, Inc.CHRSNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average, structural decline.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-20.44M
↑ 81% above average
Average (9y)
$-105.33M
Historical baseline
Range
High:$146.91M
Low:$-259.06M
CAGR
-17.4%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $-20.44M | +88.3% |
| 2023 | $-175.17M | +28.0% |
| 2022 | $-243.16M | -528.0% |
| 2021 | $-38.72M | -126.4% |
| 2020 | $146.91M | +850.4% |
| 2019 | $15.46M | +109.7% |
| 2018 | $-160.06M | +21.9% |
| 2017 | $-204.86M | +20.9% |
| 2016 | $-259.06M | -126.9% |
| 2015 | $-114.15M | - |